• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Dips 375 Points; S&P 500 Down Over 2%

    10/14/22 2:33:33 PM ET
    $FRC
    $IMRA
    $JPM
    $MS
    Commercial Banks
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $FRC alert in real time by email

    U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 375 points on Friday.

    The Dow traded down 1.25% to 29,662.76 while the NASDAQ fell 2.68% to 10,363.83. The S&P 500 also fell, dropping, 2.10% to 3,592.94.

    Also check this: Market Volatility Declines Following US Inflation Data


    Leading and Lagging Sectors


    Health care shares fell by just 0.7% on Friday. Leading the sector was strength from Reata Pharmaceuticals, Inc. (NASDAQ:RETA) and Zymeworks Inc. (NASDAQ:ZYME).


    In trading on Friday, energy shares dipped by 3.5%.


    Top Headline

     

    JPMorgan Chase & Co. (NYSE:JPM) posted better-than-expected earnings for its third quarter on Friday.


    JPMorgan Chase posted Q3 earnings of $3.12 per share, topping market expectations of $2.88 per share.

     

    Equities Trading UP


    Reata Pharmaceuticals, Inc. (NASDAQ:RETA) shares shot up 16% to $29.01. Reata Pharmaceuticals said FDA does not plan to hold advisory committee meeting to discuss the NDA for Omaveloxolone for Friedreich's Ataxia.


    Shares of Nutanix, Inc. (NASDAQ:NTNX) got a boost, shooting 23% to $26.00 following a WSJ report indicating the company is exploring a sale after receiving takeover interest.


    IMARA Inc. (NASDAQ:IMRA) shares were also up, gaining 38% to $3.57 after the company, along with Enliven Therapeutics, announced a merger agreement to combine the two companies in an all-stock transaction.


    Equities Trading DOWN

    First Republic Bank (NYSE:FRC) shares tumbled 16% to $113.28 after the company reported mixed Q3 results.


    Shares of Morgan Stanley (NYSE:MS) were down 5.5% to $74.99 after the company reported Q3 EPS and sales results down from last year.

    Novo Integrated Sciences, Inc. (NASDAQ:NVOS) was down, falling 57% to $0.32 after the company announced pricing of $2 million public offering of 4 million units at $0.50 per unit.


    Also check out: Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday


    Commodities

    In commodity news, oil traded down 3.9% to $85.67, while gold traded down 1.6% at $1,649.80.


    Silver traded down 4.1% to $18.145 on Friday while copper fell 0.9% to $3.4095.


    Euro zone


    European shares closed higher today. The eurozone’s STOXX 600 rose 0.56%, London’s FTSE 100 rose 0.12% while Spain’s IBEX 35 Index rose 0.46%. The German DAX climbed 0.67%, French CAC 40 rose 0.90% and Italy’s FTSE MIB Index gained 0.70%.

    The annual inflation rate in Spain fell to 8.9% in September from 10.5% in the prior month, while annual inflation rate in France eased to 5.6% in September from 5.9% in the previous month. Wholesale prices in Germany rose by 19.9% year-over-year in September.

     

    Economics


    US retail trade came in unchanged for September, missing market estimates for a 0.2% rise.


    Import prices in the US fell by 1.2% from a month ago in September, while export prices dropped 0.8% in September.


    US business inventories increased 0.8% from a month ago in September.


    The University of Michigan consumer sentiment climbed to 59.8 in September, recording the highest level in six months, compared to 58.6 in the prior month.


    The total number of active U.S. oil rigs climbed by 8 to 610 rigs this week, Baker Hughes Inc reported.

    Check out this: Investor Fear Eases Slightly As Dow Jumps Over 800 Points


    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 98,779,940 cases with around 1,089,910 deaths. India confirmed a total of at least 44,623,990 cases and 528,850 deaths, while France reported over 36,102,540 COVID-19 cases with 155,730 deaths. In total, there were at least 629,035,400 cases of COVID-19 worldwide with more than 6,568,520 deaths.

    Get the next $FRC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FRC
    $IMRA
    $JPM
    $MS

    CompanyDatePrice TargetRatingAnalyst
    JP Morgan Chase & Co.
    $JPM
    2/3/2026$280.00Underperform → Neutral
    Robert W. Baird
    Nutanix Inc.
    $NTNX
    1/15/2026$53.00Overweight → Equal Weight
    Barclays
    Nutanix Inc.
    $NTNX
    1/12/2026Overweight → Equal-Weight
    Morgan Stanley
    JP Morgan Chase & Co.
    $JPM
    1/7/2026Outperform → Peer Perform
    Wolfe Research
    Zymeworks Inc.
    $ZYME
    12/12/2025$33.00Equal Weight → Overweight
    Wells Fargo
    Zymeworks Inc.
    $ZYME
    12/3/2025$32.00Mkt Outperform
    Citizens JMP
    Nutanix Inc.
    $NTNX
    11/26/2025$80.00 → $65.00Buy
    Needham
    Morgan Stanley
    $MS
    11/24/2025Peer Perform → Outperform
    Wolfe Research
    More analyst ratings

    $FRC
    $IMRA
    $JPM
    $MS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    JPMorgan Chase upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded JPMorgan Chase from Underperform to Neutral and set a new price target of $280.00

    2/3/26 6:50:14 AM ET
    $JPM
    Major Banks
    Finance

    Nutanix downgraded by Barclays with a new price target

    Barclays downgraded Nutanix from Overweight to Equal Weight and set a new price target of $53.00

    1/15/26 8:33:55 AM ET
    $NTNX
    Computer Software: Prepackaged Software
    Technology

    Nutanix downgraded by Morgan Stanley

    Morgan Stanley downgraded Nutanix from Overweight to Equal-Weight

    1/12/26 8:05:47 AM ET
    $NTNX
    Computer Software: Prepackaged Software
    Technology

    $FRC
    $IMRA
    $JPM
    $MS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SKYCLARYS issued to REATA PHARMACEUTICALS INC

    Submission status for REATA PHARMACEUTICALS INC's drug SKYCLARYS (ORIG-1) with active ingredient OMAVELOXOLONE has changed to 'Approval' on 02/28/2023. Application Category: NDA, Application Number: 216718, Application Classification: Type 1 - New Molecular Entity

    2/28/23 5:14:09 PM ET
    $RETA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FRC
    $IMRA
    $JPM
    $MS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ecor1 Capital, Llc bought $635,586 worth of shares (55,421 units at $11.47) (SEC Form 4)

    4 - Zymeworks Inc. (0001937653) (Issuer)

    5/19/25 6:35:05 PM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Ecor1 Capital, Llc bought $1,456,408 worth of shares (128,713 units at $11.32) (SEC Form 4)

    4 - Zymeworks Inc. (0001937653) (Issuer)

    4/18/25 3:17:11 PM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Jpmorgan Chase & Co sold 14 shares and bought $51 worth of shares (14 units at $3.67) (SEC Form 4)

    4 - JPMORGAN CHASE & CO (0000019617) (Reporting)

    4/11/25 4:55:53 PM ET
    $JPM
    Major Banks
    Finance

    $FRC
    $IMRA
    $JPM
    $MS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nutanix Announces Date and Conference Call Information for Second Quarter Fiscal Year 2026 Financial Results

    SAN JOSE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ:NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the second quarter of fiscal year 2026, which ended January 31, 2026, after U.S. markets close on Wednesday, February 25, 2026. Nutanix will host a conference call and earnings webcast beginning at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day to discuss the company's financial results. Interested parties may access the conference call by registering at this link to receive dial in details and a unique PIN number. The conference call will also be webcast live on the Nutanix Investor Relatio

    2/5/26 4:05:00 PM ET
    $NTNX
    Computer Software: Prepackaged Software
    Technology

    Morgan Stanley to Host 17th Annual Go Red Women's Leadership Event in Collaboration with the American Heart Association

    In special recognition of the Go Red for Women® campaign, Morgan Stanley Wealth Management will collaborate with the American Heart Association in Westchester and Fairfield Counties, to host the 17th Annual Go Red Women's Leadership event on Friday, February 6 at 8:00 a.m. EST at Morgan Stanley's Purchase, NY offices. The event will also be live streamed. As in years prior, the leadership event is part of Morgan Stanley's long-standing support of the Go Red for Women® campaign, designed to celebrate the power and authentic voices of women as well as their influence and strength in numbers against a silent killer. "This event is always an opportunity to celebrate women who lead with purp

    2/5/26 10:00:00 AM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance

    The $194B Shift: How Quantum Risk Redefines Value

    Issued on behalf of QSE - Quantum Secure Encryption Corp. VANCOUVER, BC, Feb. 5, 2026 /PRNewswire/ -- USA News Group News Commentary – Capital is moving rapidly toward safety. Hybrid cloud markets swelled to $194 billion in 2026[1] as the vast majority of European enterprises rush to lock down sovereign architectures and meet strict data laws. The stakes got higher this month; federal mandates now require quantum-resistant encryption[2] for new tech purchases. This regulatory shift positions Quantum Secure Encryption Corp. (QSE) (CSE:QSE) (OTCQB:QSEGF) (FSE: VN8), Cisco (NASDAQ:CSCO), Nutanix (NASDAQ:NTNX), Digital Realty (NYSE:DLR), and DXC Technology (NYSE:DXC) as pivotal guardians in a se

    2/5/26 9:05:00 AM ET
    $CSCO
    $DLR
    $DXC
    Computer Communications Equipment
    Telecommunications
    Real Estate Investment Trusts
    Real Estate

    $FRC
    $IMRA
    $JPM
    $MS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Head of Human Resources Leopold Robin received a gift of 132 shares and gifted 132 shares, increasing direct ownership by 0.20% to 65,785 units (SEC Form 4)

    4 - JPMORGAN CHASE & CO (0000019617) (Issuer)

    2/4/26 4:18:21 PM ET
    $JPM
    Major Banks
    Finance

    New insider Mekan Sabeen claimed no ownership of stock in the company (SEC Form 3)

    3 - Zymeworks Inc. (0001937653) (Issuer)

    2/2/26 8:37:00 PM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Co-President Simkowitz Daniel A sold $6,020,313 worth of shares (32,968 units at $182.61), decreasing direct ownership by 8% to 357,342 units (SEC Form 4)

    4 - MORGAN STANLEY (0000895421) (Issuer)

    1/30/26 4:34:20 PM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance

    $FRC
    $IMRA
    $JPM
    $MS
    SEC Filings

    View All

    SEC Form FWP filed by JP Morgan Chase & Co.

    FWP - JPMORGAN CHASE & CO (0000019617) (Subject)

    2/6/26 4:17:22 PM ET
    $JPM
    Major Banks
    Finance

    SEC Form FWP filed by Morgan Stanley

    FWP - MORGAN STANLEY (0000895421) (Subject)

    2/6/26 3:51:03 PM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance

    SEC Form FWP filed by Morgan Stanley

    FWP - MORGAN STANLEY (0000895421) (Subject)

    2/6/26 2:44:50 PM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance

    $FRC
    $IMRA
    $JPM
    $MS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Zymeworks Inc.

    SC 13G/A - Zymeworks Inc. (0001937653) (Subject)

    11/14/24 9:00:57 PM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Zymeworks Inc.

    SC 13G/A - Zymeworks Inc. (0001937653) (Subject)

    11/14/24 4:27:20 PM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Zymeworks Inc.

    SC 13G - Zymeworks Inc. (0001937653) (Subject)

    11/13/24 4:30:24 PM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FRC
    $IMRA
    $JPM
    $MS
    Leadership Updates

    Live Leadership Updates

    View All

    J.P. Morgan Asset Management Welcomes Pam Hess as Retirement Strategist

    Experienced retirement research expert to help meet increased demand for actionable retirement insights NEW YORK, Jan. 27, 2026 /PRNewswire/ -- J.P. Morgan Asset Management today announced the appointment of Pam Hess as Executive Director and Retirement Strategist on the Retirement Insights team reporting to Michael Conrath, Chief Retirement Strategist. This key hire reflects the firm's ongoing commitment to investing in resources that help financial professionals, participants and plan sponsors navigate today's complex retirement landscape. In this role, Pam supports the deve

    1/27/26 10:00:00 AM ET
    $JPM
    Major Banks
    Finance

    Morgan Stanley Appoints 184 New Managing Directors

    Morgan Stanley (NYSE:MS) has announced the appointment of 184 Managing Directors. The new Managing Directors are: Sahil Aggarwal Jason B. Lynch Meg Angeles-Dayrit Jon Mace Lauren Ares Paul Madenjian Sara Banelli Dave Magoloff Arjun Bathla Anthony Maiorano Michael Beilstein Steven Markarian Aditya Bhatla Paolo Mattiello Carolee Boles Lyndal May Gilbert Borrmann Kelly McCarthy William Boyle Cameron McCarthy Eric Bradbury Eric McConnell Lucy Callaghan Michael McGillen Gerard Campbell James McNichol Alessandro C

    1/9/26 9:00:00 AM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance

    JPMorganChase Names Todd Combs to Head Strategic Investment Group of Security and Resiliency Initiative; Company Also Announces External Advisory Council to Inform SRI's Strategy and Investment Priorities

    Todd Combs to lead firm's efforts to make direct equity investments of an initial $10 billion as part of its $1.5 trillion initiative to address pressing needs in key sectors from critical minerals to frontier technologies JPMorganChase today announced that Todd Combs, Investment Manager of Berkshire Hathaway, Chief Executive Officer of GEICO and a former member of JPMorganChase's Board of Directors, will head the $10 billion Strategic Investment Group of the firm's new Security and Resiliency Initiative (SRI), which the firm recently launched to help companies enhance their growth, spur innovation and accelerate manufacturing, primarily in the United States. Combs, one of the world's lea

    12/8/25 6:02:00 AM ET
    $JPM
    Major Banks
    Finance

    $FRC
    $IMRA
    $JPM
    $MS
    Financials

    Live finance-specific insights

    View All

    Nutanix Announces Date and Conference Call Information for Second Quarter Fiscal Year 2026 Financial Results

    SAN JOSE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ:NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the second quarter of fiscal year 2026, which ended January 31, 2026, after U.S. markets close on Wednesday, February 25, 2026. Nutanix will host a conference call and earnings webcast beginning at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day to discuss the company's financial results. Interested parties may access the conference call by registering at this link to receive dial in details and a unique PIN number. The conference call will also be webcast live on the Nutanix Investor Relatio

    2/5/26 4:05:00 PM ET
    $NTNX
    Computer Software: Prepackaged Software
    Technology

    Morgan Stanley Closes Acquisition of EquityZen

    Morgan Stanley today announced that it has completed the acquisition of leading private shares platform EquityZen. "Integrating EquityZen's industry-leading technology into our private market ecosystem enhances our ability to seamlessly connect supply and demand at scale," said Jed Finn, Head of Morgan Stanley Wealth Management. "With corporate relationships spanning our Workplace channel to our Investment Bank, we're in a unique position to connect clients seeking liquidity with investors seeking private markets exposure—both increasingly in demand as companies stay private for longer and investors seek diversification." About Morgan Stanley Wealth Management Morgan Stanley Wealth Mana

    1/27/26 11:47:00 AM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance

    Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH

    SAN FRANCISCO, Jan. 22, 2026 /PRNewswire/ -- Bitwise Asset Management, a leading crypto asset manager, today announced the monthly distributions for its suite of Option Income Strategy ETFs: IMST, ICOI, IMRA, IGME, ICRC, and IETH.  Fund Ticker Distribution Per Share Distribution Rate 30-Day SEC Yield Return of Capital Ex-Date / Record Date Payment Date 1-Month Return 1-Year Return Since InceptionReturn Bitwise COIN Option Income Strategy ETF ICOI $0.50284 36.87 % 0.00 % 50.00 % 01/23/2026 01/27/2026 -4.93 % N/A -10.58 % Bitwise MARA Option Income Strategy ETF IMRA $0.20782 14

    1/22/26 4:21:00 PM ET
    $IMRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care